Insight

Yüksel Ürün: Excellent research on plasma Kidney Injury Molecule-1

Photo from Yüksel Ürün/X

May 12, 2024, 07:40

Yüksel Ürün: Excellent research on plasma Kidney Injury Molecule-1

Yüksel Ürün shared on X:

“Congratulations to Wenxin Xu and the team for their excellent research on plasma Kidney Injury Molecule-1 (pKIM-1) as a predictive tool for distinguishing renal cell carcinoma from benign renal masses. Their findings suggest that pKIM-1 could improve risk stratification and clinical outcomes for patients with suspicious renal masses.”

Proceed to the article.
Source: Yüksel Ürün/X

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.

Ankara University School of Medicine cancer JCO Journal of Clinical Oncology Kidney Injury Molecule-1 OncoDaily Oncology pKIM-1 RCC renal cell carcinoma Wenxin Xu Yüksel Ürün

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage